Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ghigo

Showing results (271-280 of 455) with videos related to

Pageof 46
Sort By:
Journal of Endocrinological Investigation|March 22, 2000
The IGF-I response to very low rhGH doses is preserved in human agingF Lanfranco, G P Ceda, J Ramunni, et al.
Journal of Endocrinological Investigation|April 9, 1999
Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humansE Arvat, L Di Vito, F Lanfranco, et al.
Clinical Endocrinology|June 10, 2000
Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosaL Gianotti, S Fassino, G A Daga, et al.
Journal of Endocrinological Investigation|February 24, 2001
Neonatal and adult human heart tissues from normal subjects and patients with ischemic, dilated or hypertrophic cardiomyopathy express insulin-like growth factor binding protein-3 (IGFBP-3)R Granata, F Broglio, D Migliorino, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 24, 2001
Effect of IGF-I administration on growth hormone secretion in obese subjectsF Tassone, L Gianotti, F Lanfranco, et al.
Journal of Endocrinological Investigation|March 1, 1994
Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administrationE Ghigo, E Arvat, G Rizzi, et al.
European Journal of Endocrinology|January 1, 1995
Effect of 15-day treatment with growth-hormone-releasing hormone alone or combined with different doses of arginine on the reduced somatotrope responsiveness to the neurohormone in normal agingE Ghigo, G P Ceda, R Valcavi, et al.
Acta Endocrinologica|August 1, 1990
Pyridostigmine partially restores the GH responsiveness to GHRH in normal agingE Ghigo, S Goffi, E Arvat, et al.
Journal of Endocrinological Investigation|July 5, 2003
Circulating ghrelin levels in newborns are not associated to gender, body weight and hormonal parameters but depend on the type of deliveryS Bellone, A Rapa, D Vivenza, et al.
Endocrinology|January 8, 1998
Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labelingH Ong, N McNicoll, E Escher, et al.
Pageof 46

Showing results (271-280 of 455) with videos related to

Sort By:
Pageof 46
Journal of Endocrinological Investigation|March 22, 2000
The IGF-I response to very low rhGH doses is preserved in human agingF Lanfranco, G P Ceda, J Ramunni, et al.
Journal of Endocrinological Investigation|April 9, 1999
Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humansE Arvat, L Di Vito, F Lanfranco, et al.
Clinical Endocrinology|June 10, 2000
Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosaL Gianotti, S Fassino, G A Daga, et al.
Journal of Endocrinological Investigation|February 24, 2001
Neonatal and adult human heart tissues from normal subjects and patients with ischemic, dilated or hypertrophic cardiomyopathy express insulin-like growth factor binding protein-3 (IGFBP-3)R Granata, F Broglio, D Migliorino, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 24, 2001
Effect of IGF-I administration on growth hormone secretion in obese subjectsF Tassone, L Gianotti, F Lanfranco, et al.
Journal of Endocrinological Investigation|March 1, 1994
Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administrationE Ghigo, E Arvat, G Rizzi, et al.
European Journal of Endocrinology|January 1, 1995
Effect of 15-day treatment with growth-hormone-releasing hormone alone or combined with different doses of arginine on the reduced somatotrope responsiveness to the neurohormone in normal agingE Ghigo, G P Ceda, R Valcavi, et al.
Acta Endocrinologica|August 1, 1990
Pyridostigmine partially restores the GH responsiveness to GHRH in normal agingE Ghigo, S Goffi, E Arvat, et al.
Journal of Endocrinological Investigation|July 5, 2003
Circulating ghrelin levels in newborns are not associated to gender, body weight and hormonal parameters but depend on the type of deliveryS Bellone, A Rapa, D Vivenza, et al.
Endocrinology|January 8, 1998
Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labelingH Ong, N McNicoll, E Escher, et al.
Pageof 46